revolutionizing vascular access

« aXess » restorative graft

Aditlys develops a novel vascular access graft using a unique material technology

Aditlys’ grafts utilize a porous material made of a patented biodegradable polymer.

Once implanted, the device triggers a unique process of tissue restoration, called Endogenous Tissue Restoration, or ETR, that eventually leads to the resorption of the graft and its replacement by an actual blood vessel.

With this particular approach, Aditlys is expecting to reduce the complications faced routinely by the patients undergoing hemodialysis. The ambition is to define a new standard of care for vascular access that will improve the quality of life of millions of people.

Early stage developments are done and the project is currently entering its final phase.
Aditlys is bringing a game changing technology in a market estimated to be worth a few billion dollars.


  • Hemodialysis
  • Current Vascular Access
  • Etr Technology


Choose an item above to learn more

Core Team

Silvere Luquin - CEO


Silvere Lucquin is a medtech entrepreneur and has a background in business and engineering. Prior to Aditlys, Silvere contributed to found CorWave, a fast-growing start-up company based out of Paris and developing innovative cardiac assist devices.

As CorWave’s employee number one, Silvere has been involved in various parts of the project, including recruiting, fund raising and R&D project management.

Silvere notably won the 2016 edition of the Worldwide Innovation Challenge (“Concours Mondial Innovation”) in the “Start-up, Silver economy” category.

Silvere started his career at SpineVision, an SME developing and commercializing innovative spine implants. He holds an MSc from Ecole Polytechnique in France and Imperial College of London in the UK as well as an MBA from INSEAD.

Luke Burke - Head of RnD


Luke Burke is the lead R&D expert for the Aditlys project and has been managing development of devices since their inception. Luke brings over 6 years of R&D experience in the fields of regenerative medicine and tissue engineering, including a PhD obtained from Swansea University (UK) on the technique of electrospinning and its application to tissue engineering.

Prior to joining Aditlys, Luke worked as a Senior R&D Engineer for Xeltis B.V., where he worked on developing manufacturing processes and lead research projects for new applications of the Xeltis technology platform. Luke started his career at Avectas Life Sciences in Dublin, ROI on bespoke engineering projects for institutions including Harvard Medical, Brigham & Women's Hospital, and Massachusetts Institute of Technology. Luke holds a PhD in chemical engineering and has authored a range of articles in peer-reviewed scientific journals.

Marc Sola - Chairman


As the chairman of Aditlys, Marc Sola brings over 20 years of experience as an entrepreneur. Marc started his first company at the age of 20 and has since founded, or co-founded, a number of businesses in different fields and multiple countries.

Marc holds a Masters of Law degree from the University of Zurich and serves on the board of various companies. Mr. Sola is a sought after speaker at international investment, asset protection and estate planning conferences worldwide. Furthermore, he has published a variety of professional articles and co-authored the book, The Insured Portfolio, published by John Wiley & Sons (2010). He is a member of YPO (Young Presidents Organization), Zurich Chapter.

Michel Darnaud - Board Member


Michel Darnaud has over 40 years of expertise as an executive and a consultant in the Medical Technology industry. Michel Darnaud serves as chairman and director of several medical technology startups including Xeltis, Stentys, Corwave. He is also chairman of Strammer and a Certified Executive Coach.

Prior, Michel was President of Cardiac Surgery at Sorin/LivaNova from 2008 to 2017. A consultant at Spencer Stuart, focusing on Medical Technology in Europe from 2005 to 2008, he was previously President Europe at Boston Scientific for seven years. He spent 19 years with Baxter International, where he became President of the European Cardiovascular Business. Michel is also a former Chairman of Eucomed, the European Medical Device Industry Association.

Advisory Team

Jean Baptiste Ricco- Special medial advisor


Professor Ricco advises Aditlys in its medical device development and clinical applications.

Professor Ricco is a member of the French National Academy of Medicine, Professor Emeritus at University of Poitiers, France and Professor Honorary at University of Strasbourg, France.
He is the former president of the European Society for Vascular Surgery (ESVS) and Chief of the vascular surgical department at the University Hospital of Poitiers, France.

In parallel to his scientific and medical accomplishments, Prof. Ricco participated to the development of numerous innovative medical technologies.

Contact us

revolutionizing revolutionizing revolutionizing revolutionizing

Baarerstrasse 137
6302 Zug

De Lismortel 31
5612AR Eindhoven
The Netherlands

Station F,
55 Boulevard Vincent Auriol
75013 Paris

Your message has been sent. Thank you!